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Abstract
Coumarin derivatives are structurally interesting compounds for synthesizing
antimicrobial and antioxidant agents. Starting from 4-methyl-7-hydroxycoumarin,
several derivatives with these properties have been obtained through different
reaction steps. Their molecular structures were established by Fourier-transform
infrared spectroscopy and nuclear magnetic resonance spectroscopy. The synthe-
sized coumarin derivatives exerted meaningful activities against Gram-positive and
Gram-negative bacteria as well as strains of Candida spp. All compounds also
exhibited high and moderate antioxidant activity in assays for DPPH inhibition,
total reducing power, and nitric oxide (NO) inhibition when compared to
ascorbic acid.
Keywords: 4-methyl-7-hydroxycoumarin, synthesis, coumarin derivatives,
antibacterial activity, antifungal activity, antioxidant activity
1. Introduction
Natural and synthetic coumarins have drawn much attention due to its broad
pharmacological activities. Literature review reveals that coumarin (2-oxo-2H-
chromene) and its derivatives represent one of the most active classes of heterocy-
clic compounds which possess a wide spectrum of biological activities [1–9]:
antitumor [1, 2], antibacterial [3, 4], antifungal [5–7], anticoagulant [8],
antioxidant [9], and anti-inflammatory [10].
1.1 Coumarins as antimicrobial agents
Over the past few decades, the search for newer antimicrobials remains an area
of intensive investigation in the field of medicinal chemistry due to resistance deve-
loped by microorganism to conventional antibiotics. Antimicrobials are one of most
significant weapons in fighting bacterial infections. Throughout history, there has
been a continual battle between humans and the multitude of microorganisms that
cause infection and disease [11, 12]. Coumarin derivatives have a wide range of
structural modifications [13], and they can serve as molecular templates for new
drugs. Coumarin derivatives are also considered as potential antimicrobial agents [14].
Medimagh-Saidana et al. reported synthesis and antimicrobial activity of some
coumarin esters (1) (Figure 1). These compounds showed good activity against
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Bacillus sp. and moderate activity against Aspergillus niger. For the data of the
antibacterial activity, these compounds were found to be active against Pseudomonas
sp. [15].
Al-Amiery et al. have synthesized some coumarin derivatives, and their anti-
fungal activity was determined based on the growth inhibition rates of the mycelia
of strains of Aspergillus niger and Candida albicans in Potato Dextrose Broth (PDB)
medium against concentrations ranging from 10 to 100 μg/ml. The compound (2)
(Figure 1) showed good activity as antifungals against fluconazole as standard drug
[16].
Behrami et al. synthesized 8-amino-4,7-dihydroxy-chromen-2-one coumarin
derivatives. The antibacterial activities of all the compounds and standard strepto-
mycin and cefalexine at concentrations of 2, 3, and 5 mg/ml were studied against
Staphylococcus aureus, Bacillus subtilis, and Escherichia coli. One compound (3)
(Figure 1) was more active than cefalexine and lesser active than streptomycin, and
it was most active among synthesized compounds [17].
Some coumarin derivatives containing thiazolidin-4-one ring were synthesized
by Rama Ganesh et al. and were screened for their antibacterial activity against
Gram-positive bacteria Staphylococcus aureus and Bacillus subtilis and Gram-negative
bacteria Klebsiella pneumonia and Escherichia coli at the concentration of
0.001 mol/ml compared with the standard drug ciprofloxacin. Zone of inhibition
of highly active compound (4) (Figure 1) was 20 mm against Staphylococcus aureus
and Bacillus subtilis [18].
1.2 Coumarins as antioxidant agents
Free radicals are molecular species capable of independent existence that contain
an unpaired electron in an atomic orbital; they are usually unstable and very reac-
tive. These species are normally produced in the human body from essential meta-
bolic processes, but they may also occur from external sources such as exposure to
X-rays, ozone, cigarette smoking, air pollutants, and industrial chemicals [19].
There is an increasing interest in antioxidants, particularly in those intended to
prevent the presumed deleterious effects of free radicals in the human body and to
prevent the deterioration of fats and other constituents of food stuffs. In both cases,
there is a preference for antioxidants from natural rather than from synthetic
Figure 1.
Coumarin derivatives with antimicrobial activity.
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sources [20]. As improved antioxidant status helps to minimize the oxidative
damage and thus delays or prevents pathological changes, potential antioxidant
therapy should be included either as natural free-radical-scavenging antioxidant
enzymes or as an agent which is capable of augmenting the activity of antioxidant
enzymes [21].
The human organism possesses natural systems to annihilate these species, but
when the body’s ability to regulate them is overwhelmed, a condition known as
oxidative stress appears, free radicals attacking important macromolecules leading
to cell damage and homeostatic disruption [22].
Many coumarin derivatives have a special ability to scavenge reactive oxygen
species and to influence processes involving free radical injury [23, 24].
Maja et al. synthesized a series of carbohydrazide with coumarin ring (5, 6) and
some coumarin derivatives with a heterocyclic ring (7, 8) (Figure 2). All these
compounds prove a good antioxidant activity [25].
Shivani et al. synthesized new coumarin-substituted derivatives of
benzothiazole, and they were evaluated for antioxidant activity by DPPH radical
scavenging activity. The test compound (9) (Figure 2) showed good in vitro
antioxidant activity [26].
2. Synthesis of coumarin derivatives
Looking to the medicinal importance of the coumarin ring, we employed
coumarin as a naturally occurring skeleton for the construction of new derivatives
which might exhibit promising antimicrobial and antioxidant activities [27].
The starting materials, 4-methyl/propyl-7-hydroxycoumarin, were prepared by
Pechmann synthesis which involved the condensation of resorcinol and ethylace-
toacetate/ethylbutyrylacetate in the presence of H2SO4 concentrate [28].
Figure 2.
Coumarin derivatives with antioxidant activity.
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2.1 Mechanism of the Pechmann condensation
The reaction is conducted with a strong Brønsted acid such as methanesulfonic
acid or a Lewis acid such as AlCl3. The acid catalyzes transesterification as well as
keto-enol tautomerization [29]. A Michael addition leads to the formation of the
coumarin skeleton. This addition is followed by rearomatization and then by elim-
ination of water which gives the product (Figure 3).
The coumarin compounds have wide interest due to their diverse pharmacolog-
ical properties. In particular, these biological activities make coumarin compounds
more attractive and testing as novel therapeutic compounds.
As part of our aim in research of biologically active coumarin derivatives, the
free hydroxyl group on the coumarin ring has allowed us to introduce some radicals
that can improve the biological activity.
The fourth scheme describes the reactions of 4-methyl/propyl-7-
hydroxycoumarin with ethyl bromoacetate. 2-Ethyl-((4-methy/propyl-2-oxo-2H-
chromen-7-yl)oxy)acetate (IIa–IIb) was prepared by heating a mixture of 4-
methyl/propyl-7-hydroxycoumarin and ethyl bromoacetate in the presence of
K2CO3 anhydrous in dry acetone. After filtration, the solution was evaporated, and
the solid products (IIa or IIb) were recrystallized from ethanol [30] (Figure 4).
The fifth scheme describes the reactions of compounds IIa–IIb with hydrazine
hydrate. The chemistry of hydrazide and its derivatives has obtained great interest
in both organic chemistry and biological science with remarkable impact. Hydra-
zides and hydrazones are possessing -NH-NH2 and -NH-N=CH- groups, respec-
tively. The availability of proton in hydrazides constitutes them as an important
class of compound for new drug discovery. Therefore, researchers have shown great
interest in developing these compounds as target structures for evaluating new
biological activities [31].
Hydrazinolysis of compounds IIa–IIb gave the corresponding acetohydrazides
(IIIa–IIIb) in good yields [30, 32]. One mole of the compound IIa or IIb in ethanol
Figure 3.
Mechanism of the Pechmann condensation.
Figure 4.
Synthesis of coumarin esters II(a-b).
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was heated for 4–6 h with hydrazine hydrate (two moles). After this period of time,
the mixture was cooled at room temperature, and the precipitate was filtrated and
then purified by recrystallization (Figure 5).
The reaction of the acid hydrazides (4-methyl/propyl-2-oxo-2H-benzopyran-7-
oxyacetic acid hydrazide) with CS2 in ethanol containing KOH at room temperature
has been presented in Figure 6. The corresponding potassium dithiocarbazate
derivatives, IVa–IVb, are obtained [32].
The obtaining of coumarin derivatives with a thiadiazole ring has been described
in Figure 7. Literature data show that pyrrole, pyrazole, thiadiazoles, and triazoles and
their derivatives are very attractive targets due to their biological properties. In view of
the above observations, we have synthesized compoundswith thiadiazole ring in order
to evaluate the potential antimicrobial and antioxidant activities.
These compounds were obtained following the reaction between potassium 4-
methyl/propyl-2-oxo-2H-benzopyranyl-7-oxymethyldithiocarbazate and acetic
acid. The reaction occurred under refluxing. The solid product was separated by
filtration and then purified by recrystallization from acetic acid [33, 34].
In the synthesis of coumarin derivatives, elemental analysis and two basic spec-
troscopic techniques, infrared spectroscopy (IR) and nuclear magnetic resonance
Figure 5.
Synthesis of coumarin acetohydrazides III(a-b).
Figure 6.
Synthesis of coumarin potassium salts IV(a-b).
Figure 7.
Synthesis of coumarin thiadiazoles derivatives V(a-b).
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spectroscopy (NMR), were used to characterize the structures of the target com-
pounds [35].
The physical constants and analytical data of compounds Ia–Ib, IIa–IIb,
IIIa–IIIb, IVa–IVb, and Va–Vb have been given in Tables 1–5.
Compd. R MP °C Molecular formula Analysis found (calculated) (%)
C H
Ia H3C▬ 185 C10H8O3 68.18
68.02
4.58
4.55
Ib H3C▬CH2▬CH2▬ 130 C12H12O3 70.57
70.21
5.92
5.69
Table 1.
Physical constants and analytical data of compounds Ia–Ib.
Compd. R MP °C Molecular formula Analysis found (calculated) (%)
C H
IIa H3C▬ 100–102 C14H14O5 64.12
64.10
5.38
5.22
IIb H3C▬CH2▬CH2▬ 98 C16H18O5 66.19
65.89
6.25
6.05
Table 2.
Physical constants and analytical data of compounds IIa–IIb.
Compd. R MP °C Molecular formula Analysis found (calculated) (%)
C H
IIIa H3C▬ 204–205 C12H12N2O4 58.06
57.98
4.87
4.80
IIIb H3C▬CH2▬CH2▬ 147–148 C14H16N2O4 60.86
60.56
5.84
5.76
Table 3.
Physical constants and analytical data of compounds IIIa–IIIb.
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The IR spectra of all synthesized compounds showed some characteristic peaks
indicating the presence of particular groups (Tables 6–10).
1H-NMR spectra of the synthesized compounds are in accordance with the
assigned structures (Table 11). The aliphatic protons resonated in the range of
1.20–4.77 ppm. It can be seen that all the compounds exhibited the respected proton
chemical shifts in the same range.
Compd. R MP °C Molecular formula Analysis found (calculated) (%)
C H
IVa H3C▬ 184 C13H11N2O4KS2 43.08
42.87
3.06
3.01
IVb H3C▬CH2▬CH2▬ 176–178 C15H15N2O4KS2 46.13
46.02
3.87
3.76
Table 4.
Physical constants and analytical data of compounds IVa–IVb.
Compd. R MP °C Molecular formula Analysis found (calculated) (%)
C H
Va H3C▬ 267–268 C13H10N2O3S2 50.97
50.63
3.29
3.06
Vb H3C▬CH2▬CH2▬ 172 C15H14N2O3S2 53.87
53.33
4.22
4.12
Table 5.
Physical constants and analytical data of compounds Va–Vb.
Compd. R υO-H cm
1 υC-H aliph cm
1 υC=O lactone cm
1 υC-O cm
1
Ia H3C▬ 3280 2950 1680 1150
Ib H3C▬CH2▬CH2▬ 3195 2970 1695 1140
Table 6.
IR spectral data of compounds Ia–Ib.
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Compd. R υC-H arom cm
1 υC=O side chain cm
1 υC=O lactone cm
1
IIa H3C▬ 3070 1750 1680
IIb H3C▬CH2▬CH2▬ 3080 1740 1690
Table 7.
IR spectral data of compounds IIa–IIb.
Compd. R υNH2 cm
1 υCO-NH cm
1 υC-N cm
1
IIIa H3C▬ 3423, 3331 1612 1271
IIIb H3C▬CH2▬CH2▬ 3411, 3340 1610 1260
Table 8.
IR spectral data of compounds IIIa–IIIb.
Compd. R υN-H cm
1 υC=S cm
1
IVa H3C▬ 3210 1240
IVb H3C▬CH2▬CH2▬ 3150 1210
Table 9.
IR spectral data of compounds IVa–IVb.
Compd. R υS-H cm
1 υC=N cm
1 υS-C cm
1
Va H3C▬ 2380 1610 621
Vb H3C▬CH2▬CH2▬ 2350 1620 638
Table 10.
IR spectral data of compounds Va–Vb.
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3. Pharmacological activities of coumarin derivatives
3.1 Antimicrobial activity
The compounds were screened for their antibacterial and antifungal activity
according to standard protocols [36].
The antimicrobial activity was studied using Gram-positive bacteria (Staphylo-
coccus aureus ATCC 25923, Sarcina lutea ATCC 9341, Bacillus cereus ATCC 14579),
Gram-negative bacteria (Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC
27853), and pathogenic yeasts (Candida albicans ATCC 10231, Candida glabrata
ATCC MYA 2950, Candida parapsilosis ATCC 22019). All these strains were
obtained from the Culture Collection of the Department of Microbiology, Faculty of
Pharmacy, “Grigore T. Popa” University of Medicine and Pharmacy, Iasi, Romania.
Compd. R Chemical shift (δ ppm) 500 MHz
Ia H3C▬ 2.73 ppm s, 3H: CH3; 6.04 ppm s, H3; 6.72 ppm s, H8; 6.83–6.85 ppm d, H6,
JH6,H5 = 7.5 Hz; 7.62–7.64 ppm d, H5, JH5,H6 = 7.5 Hz; 10.85 ppm s, 1H: OH
Ib H3C▬CH2▬CH2▬ 1.20 ppm t, 3H: CH3 (12); 1.66 ppm m, 2H: CH2 (11); 2.81–2.84 ppm m,
2H: CH2 (10); 6.11 ppm s, H3; 6.72 ppm s, H8; 6.84–6.85 ppm d, H6, JH6,
H5 = 7.5 Hz; 7.63–7.65 ppm d, H5, JH5,H6 = 7.5 Hz; 10.86 ppm s, 1H: OH
IIa H3C▬ 1.26–1.28 ppm t, 3H: CH3 (14); 2.73 ppm s, 3H: CH3; 4.25–4.28 ppm m,
2H: CH2 (13); 4.61 ppm s, 2H: CH2 (10); 6.04 ppm s, H3; 6.84 ppm s, H8;
7.05–7.07 ppm d H6; 7.62–7.64 ppm d, H5
IIb H3C▬CH2▬CH2▬ 0.95–0.98 ppm t, 3H: CH3 (17); 1.20–1.23 ppm t, 3H: CH3 (14); 1.60–
1.65 ppm m, 2H: CH2 (16); 2.72–2.75 ppm t, 2H: CH2 (15); 4.15–
4.20 ppm m, 2H: CH2 (13); 4.92 ppm s, 2H: CH2 (10); 6.17 ppm s, H3;
6.98 ppm s, H8; 6.96–6.97 ppm d H6; 7.73–7.75 ppm d, H5
IIIa H3C▬ 2.74 ppm s, 3H: CH3; 3.86 ppm s, 2H: NH2 (13); 4.42 ppm s, 2H: CH2 (10);
6.03 ppm s, H3; 6.83 ppm s, H8; 7.05–7.07 ppm d; 7.62–7.64 ppm d, H5;
8.02 ppm s, NH (12)
IIIb H3C▬CH2▬CH2▬ 0.95–0.98 ppm t, 3H: CH3 (16); 1.59–1.66 ppm m, 2H: CH2 (15); 2.72–
2.75 ppm t, 2H: CH2 (14); 4.35 ppm s, 2H: NH2 (13); 4.61 ppm s, 2H: CH2
(10); 6.17 ppm s, H3; 6.98 ppm s, H8; 6.99–7.00 ppm d H6; 7.74–7.76 ppm
d, H5; 9.42 ppm s, NH (12)
IVa H3C▬ 2.71–2.74 ppm d, 3H: CH3; 4.41–4.43 ppm s, 2H: CH2 (10); 6.02–6.05 ppm
q, H3; 6.82–6.84 ppm d, H8; 7.05–7.08 ppm q H6; 7.62–7.64 ppm d, H5;
9.94 ppm s, NH (12); 11.23 ppm s, NH (13)
IVb H3C▬CH2▬CH2▬ 1.20–1.22 ppm t, 3H: CH3 (18); 1.62–1.66 ppm m, 2H: CH2 (17);
2.79–2.82 ppm t, 2H: CH2 (16); 4.40 ppm s, 2H: CH2 (10); 6.10 ppm s, H3;
6.84 ppm s, H8; 7.04–7.08 ppm q H6; 7.62–7.66 ppm d, H5; 9.95 ppm s, NH
(12); 11.25 ppm s, NH (13)
Va H3C▬ 2.39 ppm s, 3H: CH3; 4.77 ppm s, 2H: CH2 (10); 6.23 ppm s, H3;
6.99 ppm s, H8; 7.02–7.04 ppm d H6; 7.70–7.72 ppm d, H5; 10.29 ppm s,
SH (16)
Vb H3C▬CH2▬CH2▬ 0.95–0.98 ppm t, 3H: CH3 (19); 1.60–1.65 ppm m, 2H: CH2 (18);
2.72–2.75 ppm t, 2H: CH2 (17); 4.77 ppm s, 2H: CH2 (10); 6.17 ppm s, H3;
6.98 ppm s, H8; 6.99–7.00 ppm d H6; 7.75–7.76 ppm d, H5; 11.27 ppm s,
SH (16)
Table 11.
1H-NMR spectral data of compounds I–V.
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Antimicrobial activity was evaluated by agar disc diffusion method (CLSI,
2014). A small amount of each microbial culture was diluted in sterile 0.9% NaCl
until the turbidity was equivalent to McFarland standard no. 0.5 (106 CFU/ml). The
suspensions were further diluted 1:10 in Mueller-Hinton agar for bacteria and
Sabouraud agar for yeasts and then spread on sterile Petri plates (25 ml/Petri plate).
Sterile stainless steel cylinders (5 mm internal diameter; 10 mm height) were
applied on the agar surface in Petri plates. Then, 0.1 ml of each compound
(10 mg/ml in DMSO) was added into the cylinders. The DMSO solvent was also
tested in order to assess its intrinsic antimicrobial activity. Commercial available
discs containing ampicillin (25 μg/disc), chloramphenicol (30 μg/disc), and nystatin
(100 μg/disc) were also placed on the agar surface. The plates were incubated at
37°C for 24 h (bacteria) and at 24°C for 48 h (yeasts). After incubation the diame-
ters of inhibition zones were read in triplicate. Statistical analysis of the results
included the calculation of standard deviation (Tables 12 and 13).
The qualitative screening of the antimicrobial activity was performed in order to
identify the antimicrobial spectrum of the tested compounds. The inhibitory effects
of the synthetic compounds against Gram-positive and Gram-negative bacteria and
fungi are given in Tables 12 and 13 [35].
According to the results of the antibacterial studies, the efficacy of the tested
compounds against Gram-positive bacteria was higher than that exhibited for
Gram-negative bacteria. All the synthesized compounds were very active against
S. aureus ATCC 25923, the most active compounds being Ib, IIb, IIIb, and IVb. The
replacement of the methyl radical in the fourth position with the propyl group was
correlated with an increased activity against S. aureus ATCC 25923.
The tested compounds exhibited excellent antibacterial activity against S. lutea,
the most active derivatives being IIb, IVb, Ib, and IIIb.
Compd./reference Diameters of the growth inhibition zone (mm)
S. aureus
ATCC 25923
S. lutea
ATCC 9341
B. cereus
ATCC 14579
E. coli
ATCC
25922
Pseudomonas
aeruginosa
ATCC 27853
Ia 14  0.52 25  0.79 25  1.52 12  0.79 8  0.93
Ib 27  1.29 29  0.83 NA NA NA
IIa 14  0.91 22  0.79 26  0.79 11  0.52 8  1.43
IIb 27  0.52 30 NA NA NA
IIIa 15  0.54 20  0.79 22  0.79 10  0.79 9  0.79
IIIb 25  0.52 28 NA NA NA
IVa 17  1.08 25  0.91 24  1.52 12  0.93 9  1.43
IVb 25  1.08 30  0.83 NA NA NA
Va 14  0.52 25  0.52 20  1.43 10  1.52 8  0.52
Vb 21  1.43 25  0.79 NA 13  0.83 NA
Ampicillin
(25 μg/disc)
26  0.04 36  0.00 NA 21  0.79 NA
Chloramphenicol
(30 μg/disc)
22  0.00 38  0.00 24  0.00 21  0.52 NA
Data are mean  SD (n = 3); NA, no activity.
Table 12.
Antibacterial activity of compounds I–V.
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We found a moderate action against B. cereus ATCC 14579, the most active being
the umbelliferone derivatives with a methyl group attached to C4: IIa, Ia, and IVa.
Against Escherichia coli ATCC 25922, the investigated compounds had a weaker
action than the controls ampicillin and chloramphenicol. The most active was the
compound that contains a thiadiazole ring, Vb.
The presence of the methyl group attached to the coumarin ring in the fourth
position had a positive influence on the anti-Pseudomonas ATCC 27853 potential of
the compounds, all the tested 4-propyl-coumarin derivatives being inactive.
We have noticed a very important action against the investigated Candida
strains; all tested compounds were found to be very active against fungi. The
compounds IIa and Ia had a greater inhibitory potential against C. parapsilosis
ATCC 22019 than nystatin. The introduction of the sulfur atom appeared to be
correlated with a good anti-Candida activity.
3.2 Antioxidant activity
In order to evaluate the antioxidant activity of synthesized compounds, we use
three antioxidant assays: DPPH radical inhibition, total reducing power, and nitric
oxide (NO) inhibition.
The DPPH assay is based on assessing the substances’ ability to reduce the stable
radical (diphenylpicrylhydrazyl) to diphenylpicrylhydrazine. The DPPH free radi-
cal, bearing an odd electron, gives a strong absorption maximum at λ = 517 nm
(purple color). When the odd electron of the DPPH radical pairs with a hydrogen
atom from an antioxidant, the reduced form DPPH-H is created, and the color turns
from purple to yellow [36, 37].
A possible mechanism that can explain the antioxidant effect of the coumarin
hydrazide derivatives is related to the keto-enol forms of the substances, the enol
group being capable to easily donate the hydrogen (Figure 8) [38].
The experimental procedure for the DPPH assay was adapted from literature
[27, 28, 37], only slight modifications being made. Briefly, 2.5 ml solution of DPPH
(2,2-diphenyl-1-picrylhydrazyl) radical 0.1 mM in methanol was added over 0.5 ml
Compd./reference Diameters of the growth inhibition zone (mm)
C. albicans
ATCC 10231
C. glabrata
ATCC MYA 2950
C. parapsilosis
ATCC 22019
Ia 24  1.83 21  0.52 34  1.83
Ib 10  0.91 10  0.79 10  0.54
IIa 25  0.52 27  0.54 35  1.83
IIb 9  1.83 NA NA
IIIa 19  1.79 24  0.52 24  1.79
IIIb 12  1.83 11  0.54 11  0.54
IVa 23  0.91 16  0.52 25  1.08
IVb 10  0.54 12  1.08 NA
Va 16  1.79 21  1.83 21  0.54
Vb 9  0.54 9  0.52 NA
Nystatin (100 μg/disc) 25  0.52 25  0.52 24  0.00
Data are mean  SD (n = 3); NA, no activity.
Table 13.
Antifungal activity of compounds I–V.
11
Coumarin Derivatives with Antimicrobial and Antioxidant Activities
DOI: http://dx.doi.org/10.5772/intechopen.88096
of methanolic solution of the tested compound (1 mg/ml). The absorbance of the
DPPH solution at 517 nm was determined spectrophotometrically before (Acontrol)
and 15 minutes after adding the solutions of the compounds (Atest), and the per-
centage of activity was calculated. Ascorbic acid was used as a reference compound:
% radical scavenging activity ¼ Acontrol  Atestð Þ  100=Acontrol
where Acontrol is the absorbance of the control sample (DPPH solutionwithout test
sample) andAtest is the absorbance of the test sample (DPPHsolution+ test compound).
Out of the tested compounds, the most active DPPH free radical scavengers
were the coumarin hydrazide derivatives (IIIa–IIIb, IVa–IVb). The activities of
IVa were similar to that of the standard, the inhibition percentage being over 90%,
the introduction of sulfur atoms in the molecule having a positive influence on the
scavenging potential. Compounds IIIa and IVa, containing a methyl group, were
slightly more active than their analogues with propyl radical (Table 14) [19].
Fe(III) reduction is often used as an indicator of electron-donating activity. In
the reducing power assay, antioxidants with electron-donating abilities reduce fer-
ricyanide to ferrocyanide by donating an electron. The amount of ferrocyanide is
monitored by measuring the formation of Perl’s Prussian blue at 700 nm. Increasing
absorbance at 700 nm indicates an increase in reducing ability [39]. Within this
assay, EC50 values are the effective concentrations at which the absorbance is 0.5.
The solution of the test compound (0.5 ml) at different concentrations in meth-
anol was mixed with phosphate buffer (1.25 ml, 0.2 mol/l, pH 6.6) and potassium
ferricyanide 1% (1.25 ml), and the mixture was incubated at 50°C for 20 min. At the
end of the incubation period, trichloroacetic acid 10% (1.25 ml) was added to the
mixture and centrifuged at 3000 rpm for 10 min. The upper layer solution was
collected, and 2.5 ml were mixed with distilled water (2.5 ml) and ferric chloride
0.1% (0.5 ml). The absorbance was measured after 15 min at 700 nm against a
blank. The EC50 values were calculated by linear interpolation between values
above and below 50% activity. Ascorbic acid was used as reference [28, 30, 36, 37].
The reducing power of the tested compounds was modest, and the results are
presented in Table 15. The only substances that were moderately active were the
hydrazide derivatives IIIa and IVa, but their activity was inferior to that exhibited
by the reference substance (ascorbic acid) [19].
Figure 8.
Proposed mechanism for antioxidant activity of coumarin hydrazides.
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The calculated values for EC50 are shown in Table 16. This method could not be
applied to compound IIIb due to the formation of an abundant precipitate in the
process.
Nitric oxide is involved in a variety of biological functions (neurotransmission,
vascular homeostasis, antimicrobial and antitumor activities). NO was primarily
Compd. Extinction
Ia 0.0599
Ib 0.0105
IIa 0.0234
IIb 0.0010
IIIa (1 mg/ml) 1.3432
(0.8 mg/ml) 1.1237
(0.6 mg/ml) 1.0821
(0.4 mg/ml) 0.9674
(0.2 mg/ml) 0.5499
IVa (1 mg/ml) 0.6592
(0.8 mg/ml) 0.5900
(0.6 mg/ml) 0.4854
(0.4 mg/ml) 0.4258
(0.2 mg/ml) 0.2785
IVb 0.4887
Va 0.0472
Vb 0.3063
Ascorbic acid
1 mg/ml
2.8261
Table 15.
The reducing power of compounds I–V.
Compd. Inhibition percentage (%)
Ia 21.4
Ib 21.2
IIa 19
IIb 19.83
IIIa 73
IIIb 53.56
IVa 95
IVb 87.67
Va 31.51
Vb 25.13
Ascorbic acid
1 mg/ml
96.8
Table 14.
DPPH inhibition percentages of compounds I–V (1 mg/ml).
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described as a regulator of vascular tones in the cardiovascular system. Beyond this
function it can prevent platelet activation, limit leukocyte adhesion to the endothe-
lium, and regulate myocardial contractility, and it is involved in immune system
reactions.
Despite the possible beneficial effects of NO, it also contributes to oxidative
damage. In general, the overwhelming production of NO contributes to the patho-
genesis of both acute and chronic inflammatory processes, and NO has been recog-
nized as one of the main signaling molecules involved in these processes [23, 40].
Therefore, compounds that act like nitric oxide inhibitors have beneficial effects.
The NO inhibition assay is based on the diazotization of sulfanilic acid at acid pH
by nitric oxide. The reaction product is subsequently coupled stoichiometrically
with N-(1-naphthyl)ethylenediamine, forming a colored azo compound which is
measured spectrophotometrically at a peak absorbance of 548 nm [36].
0.5 ml of the tested coumarin derivative solution, as well as ascorbic acid (stan-
dard compound), was taken in separate tubes, and 2.0 ml of sodium nitroprusside
Compd. EC50 (mg/ml)
Ia >>1
Ib >>1
IIa >>1
IIb >>1
IIIa 0.176
IVa 0.627
IVb 1.02
Va >>1
Vb >1
Ascorbic acid
1 mg/ml
0.049
Table 16.
The calculated values of EC50.
Compd. NO inhibition (%)
Ia 15.2
Ib 19.8
IIa 12.11
IIb 14.7
IIIa 22.8
IIIb 55.5
IVa 28.45
IVb 29.44
Va 22.6
Vb 26
Ascorbic acid
50 mg/ml
77.19
Table 17.
NO inhibition activity of compounds I–V.
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(10 mM) and 0.5 ml phosphate buffer saline (pH = 7.4) were added to each tube.
The solutions were incubated at 25°C for 150 minutes. After the incubation, over
0.5 ml of the incubated solution 1 ml of sulfanilic acid 0.33% was added, and the
mixture was left for 5 min at room temperature; after this period of time, 1 ml
naphthylethylene diamine (NED) HCl reagent 0.1% was added, and the solutions
were incubated for another 30 min. The absorbance was measured at 546 nm [38].
Most of the investigated compounds were moderate NO inhibitors (Table 17) [19].
4. Concluding remarks
We have synthesized some coumarin derivatives starting from 4-methyl-7-
hydroxycoumarin with antimicrobial and antioxidant activities to different reaction
steps. The IR and NMR spectra of the synthesized compounds were in accordance
with the assigned structures. All the synthesized compounds were very active
against S. aureus ATCC 25923, and they exhibited excellent antibacterial activity
against S. lutea. The presence of the methyl group attached to the coumarin ring in
the fourth position had a positive influence on the anti-Pseudomonas ATCC 27853
potential of the compounds, all the tested 4-propyl-coumarin derivatives being
inactive. Against the investigated Candida strains, all tested compounds were found
to be very active. The introduction of the sulfur atom appeared to be correlated with
a good anti-Candida activity. The most active DPPH free radical scavengers were
the coumarin hydrazide derivatives, the activities of these being similar to that
of the standard. The reducing power of the tested compounds was modest, and
only the hydrazide derivatives were moderately active. Most of the investigated
compounds were moderate NO inhibitors.
The interest in the synthesis of coumarin derivatives has been gaining impor-
tance over the last decades, reflecting the importance of such compounds in both
medical and chemical research. Future goals for this field of research include the
discovery, synthesis, and development of compounds which display increased
potency, as well as fueling structure–activity relationship studies aimed at under-
standing the modes of action of the most biologically active members of these
classes of products.
Although coumarin is a simple molecule and many of its derivatives have been
known for more than a century, it continues to maintain the interest of researchers
being a plentiful source of potential drug candidate because of their significant
therapeutic potential.
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